Acrux Ltd has released a press release.
Appendix 4D and Half Year Accounts - for the 31 Dec ac
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Acrux
- Share Purchase Plan Closes Oversubscribed
- Acrux Receives FDA Approval - Generic Testosterone Solution
- Acrux Ltd Share Purchase Plan Offer Booklet
- Acrux Raises $7.8m Via Placement and Announces SPP
- Acrux Signs Licensing Agreement with Dash Pharmaceuticals
Later from Acrux
- Acrux Investor Presentation
- Acruxs fourth generic dossier accepted by FDA for review
- Acrux confirms patent challenge
- Acrux Receives FDA Approval - Generic Efinaconazole Solution
- Acrux receives third FDA ANDA approval
Follow Acrux into a list and get an email when it puts out news.
Follow Acrux